Economic and sustainable revolution to facilitate one-carbon biomanufacturing.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 40425587.
- Also identified by DOI 10.1038/s41467-025-60247-w and PMC identifier 12117142.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
One-carbon (C1) biomanufacturing serves as a substitute for fossil-based feedstocks, aiming to de-fossilize chemical production and foster a circular carbon economy by recycling waste greenhouse gases. Here, we review the key economic and technical barriers associated with the commercialization of C1 biomanufacturing through case studies. Additionally, a viable roadmap to enhance cost competitiveness is unveiled, underscoring its potential to facilitate carbon neutrality as scalable and sustainable alternatives to traditional chemical production.
Medical subject headings
- Carbon
- Biotechnology